A detailed history of Syon Capital LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Syon Capital LLC holds 26,869 shares of NVO stock, worth $2.36 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
26,869
Previous 28,005 4.06%
Holding current value
$2.36 Million
Previous $4 Billion 19.97%
% of portfolio
0.28%
Previous 0.37%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $135,263 - $165,197
-1,136 Reduced 4.06%
26,869 $3.2 Billion
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $29,818 - $35,699
243 Added 0.88%
28,005 $4 Billion
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $4,799 - $6,388
-47 Reduced 0.17%
27,762 $3.56 Billion
Q4 2023

Feb 02, 2024

BUY
$87.78 - $105.45 $404,841 - $486,335
4,612 Added 19.88%
27,809 $2.88 Billion
Q3 2023

Nov 03, 2023

BUY
$90.94 - $199.54 $2.11 Million - $4.63 Million
23,197 New
23,197 $2.11 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Syon Capital LLC Portfolio

Follow Syon Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syon Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syon Capital LLC with notifications on news.